Exploring GIPC2 as a key prognostic marker in colorectal cancer linked to enhanced immune response
Authors:
Open Access
- 17 June 2025
- journal article
- Published by Elsevier in Immunobiology
- Vol. 230 (4) , 153090
Abstract
No abstract availableKeywords
Funding Information
- Shandong University (2022YP10)
This publication has 37 references indexed in Scilit:
- Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implicationsBiomedicine & Pharmacotherapy, 2023
- Synchronous Neoplasia Rates at Colonoscopic Diagnosis of Early-Onset vs Average-Onset Colorectal CancerJAMA Network Open, 2023
- PDZ‐binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathwayMolecular Carcinogenesis, 2023
- Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumorsCancer Communications, 2022
- Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancerJournal of Gastroenterology, 2021
- Strength and duration of GIPC-dependent signaling networks as determinants in cancerNeoplasia, 2021
- Biophysical analysis of the plant-specific GIPC sphingolipids reveals multiple modes of membrane regulationJournal of Biological Chemistry, 2021
- Depletion of gipc-1 and gipc-2 causes infertility in Caenorhabditis elegans by reducing sperm motilityBiochemical and Biophysical Research Communications, 2021
- The Challenges of Tumor Mutational Burden as an Immunotherapy BiomarkerCancer Cell, 2020
- GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin PathwayCellular and Molecular Gastroenterology and Hepatology, 2020